Skip to main content
Clinical Trials/NCT03744494
NCT03744494
Completed
Not Applicable

Comparison of the Therapeutic Efficacy and Patient Satisfaction of Three Techniques of Bilateral Orchidectomy in Prostate Cancer Patients of a Nigerian Sub-population (TEPSO)

University College Hospital, Ibadan1 site in 1 country63 target enrollmentMarch 2, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
University College Hospital, Ibadan
Enrollment
63
Locations
1
Primary Endpoint
Summative and domain quality of life scores
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The therapeutic efficacy of three types of orchidectomy was ascertained as well as the QoL and scrotal cosmetic satisfaction of patients in the three surgical arms. Two of these surgeries produced a pseudotesticle (BSCO, BESO) while one (BSO) did not.

Detailed Description

Patients with prostate cancer (PCa) were grouped into three surgical arms: BSO (bilateral simple orchidectomy), BSCO (bilateral subcapsular orchidectomy) and BESO (bilateral epididymal-sparing orchidectomy). Preoperatively, baseline serum testosterone, PSA, Quality of life (QoL) and pre-operative testicular volumes were obtained. Timed interval sampling for serum testosterone and PSA variation was done post-operatively. By three months post-op, the cosmetic appeal of the scrotal appearance, post-operative pseudotesticular volumes and QoL were also assessed. The therapeutic efficacy of the surgeries was determined by the rates of decline of serum testosterone and PSA, as well as the nadirs achieved. The variations in the pre-and post-operative QoL was analysed.

Registry
clinicaltrials.gov
Start Date
March 2, 2016
End Date
February 26, 2018
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
University College Hospital, Ibadan
Responsible Party
Principal Investigator
Principal Investigator

I.N. Chibuzo

Principal Investigator

University College Hospital, Ibadan

Eligibility Criteria

Inclusion Criteria

  • Consecutive consenting patients with histologically confirmed locally advanced or metastatic PCa who have accepted to have an orchidectomy

Exclusion Criteria

  • Patients who have had bilateral orchidectomy
  • Those who opt for medical castration

Outcomes

Primary Outcomes

Summative and domain quality of life scores

Time Frame: Three months

Life Satisfaction -8 questionnaire was used to complement the EPIC-26 in the QoLassessment pre-and post-operatively. Lisat-8 is ranked from 1 to 6, with 5 and 6 denoting satisfaction (5: Satisfying; 6: Satisfying) while scores of 4 and below connote varied degrees of dissatisfaction (1: very dissatisfying; 2: Dissatisfying; 3: Rather dissatisfying; 4: Rather satisfying) EPIC 26 scores are ranked from 0 to 100 with higher scores indicating better function and less bother. Urinary incontinence, Lower Urinary Tract Symptoms, Bowel function/bother, Sexual function/bother, Hormone and vitality were assessed.

Change in pseudotesticular volume

Time Frame: Three months

A Prader orchidometer was used to measure the pre-operative testicular volume and post-operative pseudotesticular volume in cm3

Satisfaction with scrotal appearance

Time Frame: three months after the orchidectomy

Patient rating of cosmetic appeal of the scrotum using a graduated Visual Analog Scale rated between 0 and 100 to signify a score of 0 to 100%. Higher values indicated better satisfaction with scrotal appearance

Secondary Outcomes

  • Serum PSA levels(Three months (timed interval sampling))
  • Serum testosterone levels(Three months (timed interval sampling))

Study Sites (1)

Loading locations...

Similar Trials